Publication date: Oct 17, 2024
To examine the prevalence of drug use among individuals (age 16+) injured in non-fatal motor vehicle crashes (MVCs) from 2019 to 2023 and assess regional differences based on US Census regions (i. e., West, Midwest, Northeast, and South), and thereby contribute to a comprehensive understanding of drug-related MVCs. We examined emergency medical services data from 19 US states (January 2019 to December 2023) to determine the annual mean drug use prevalence among individuals (age 16+) injured in non-fatal MVCs. Differences in drug use prevalence were assessed using ANOVA with the Tukey-Kramer test for year-to-year comparisons. Adjusted Poisson regression models with random effect for states were used to compare trends to the baseline (i. e., 2019) and to assess regional differences. Among individuals (age 16+) injured in non-fatal MVCs, 62,310 had reported drug use. ANOVA results showed significant year-to-year differences in the prevalence of drug use among individuals injured in non-fatal MVCs, with an increase from 2019 to 2020 and a subsequent decrease from 2020 to 2023 (p
| Concepts | Keywords |
|---|---|
| December | driving |
| Injured | Drug use |
| Midwest | DUID |
| Models | motor vehicle crash |
| substance use | |
| traffic injury |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | emergency |
| disease | MESH | substance use |